Published in Neurology on May 27, 2003
Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol (2013) 1.11
Dementia with Lewy bodies. Dialogues Clin Neurosci (2004) 0.80
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord (2003) 4.56
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry (2004) 2.12
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord (2006) 2.04
Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry (2009) 1.91
LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol (2006) 1.72
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci (2005) 1.65
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry (2007) 1.52
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol (2006) 1.29
Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord (2003) 1.27
Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry (2010) 1.26
Operationalization of mild cognitive impairment: a graphical approach. PLoS Med (2007) 1.22
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging (2002) 1.19
A comparison of computerized and pencil-and-paper tasks in assessing cognitive function in community-dwelling older people in the Newcastle 85+ Pilot Study. J Am Geriatr Soc (2007) 1.14
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis (2004) 1.13
Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities. Int Psychogeriatr (2009) 1.13
Hippocampal sclerosis dementia: expanding the phenotypes of frontotemporal dementias? Neurology (2004) 1.05
Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Res (2009) 1.04
How to diagnose dementia with Lewy bodies: state of the art. Mov Disord (2005) 1.04
Lewy body dementia: caregiver burden and unmet needs. Alzheimer Dis Assoc Disord (2010) 1.03
Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol (2003) 1.00
Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol (2004) 0.98
Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord (2010) 0.98
Dementia with Lewy bodies. Semin Neurol (2007) 0.97
MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 0.97
Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. Int J Geriatr Psychiatry (2012) 0.97
Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Demen (2010) 0.95
The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality of life. Dement Geriatr Cogn Disord (2006) 0.94
Caffeine: neuroprotective functions in cognition and Alzheimer's disease. Am J Alzheimers Dis Other Demen (2009) 0.92
The influence of beta-blockers on delayed memory function in people with cognitive impairment. Am J Alzheimers Dis Other Demen (2007) 0.91
Has the management of Alzheimer's disease changed over the past 100 years? Lancet (2006) 0.89
Lewy body dementia. Int Rev Neurobiol (2009) 0.89
Reaching the population with dementia drugs: what are the challenges? Int J Geriatr Psychiatry (2007) 0.88
Alzheimer's disease and other dementias: a review. Am J Alzheimers Dis Other Demen (2002) 0.86
Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease. J Neurol Sci (2006) 0.86
A clinical approach to early-onset inheritable dementia. Am J Alzheimers Dis Other Demen (2012) 0.86
Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology (2003) 0.86
Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis. Int J Geriatr Psychiatry (2007) 0.86
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials (2009) 0.86
Alpha-Synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level. Am J Alzheimers Dis Other Demen (2005) 0.85
Cognition and amyotrophic lateral sclerosis (ALS). Am J Alzheimers Dis Other Demen (2007) 0.83
Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study. BMJ Open (2012) 0.83
Progranulin and beta-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier. Am J Alzheimers Dis Other Demen (2009) 0.82
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Conscious Cogn (2002) 0.81
Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiol Dis (2005) 0.81
What explains variations in the clinical use of mild cognitive impairment (MCI) as a diagnostic category? Int Psychogeriatr (2008) 0.80
Alzheimer neuropathology in nondemented aging: keeping mind over matter. Neurology (2006) 0.80
Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies. Am J Alzheimers Dis Other Demen (2008) 0.80
Presenilin-1 C410Y Alzheimer disease plaques contain synaptic proteins. Am J Alzheimers Dis Other Demen (2007) 0.80
Dementia: many roads, but not built in a day. Neurology (2007) 0.78
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: some comments. Int Psychogeriatr (2010) 0.78
The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dement Geriatr Cogn Disord (2005) 0.77
Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance. Int J Geriatr Psychiatry (2010) 0.77
Effects of prescribed medications on cognition and behavior in frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2010) 0.77
Cerebrospinal immunoglobulin level changes and clinical response to treatment of Hashimoto's encephalopathy. Am J Alzheimers Dis Other Demen (2009) 0.76
Association between progranulin and beta-amyloid in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen (2009) 0.76
Dementia with Lewy bodies and other difficult diagnoses. Int Psychogeriatr (2004) 0.76
Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. Neurosci Lett (2004) 0.76
Uplifting news for frontotemporal dementia: The sagging brain syndrome. Neurology (2011) 0.75
Dementia with Lewy bodies. Handb Clin Neurol (2007) 0.75
Tarot decks and PET scans: predicting the future of MCI. Neurology (2010) 0.75
Characterizing clinical phenotypes: the Lewys in their life or the life of their Lewys? Neurology (2006) 0.75
Compensating for Alzheimer lesions: evidence that size counts. Neurology (2009) 0.75
Genetic aspects of Alzheimer's disease, Pick's disease, and other dementias. Am J Alzheimers Dis Other Demen (2004) 0.75
Caffeine, ethical and practical challenges, and nonpharmaceutical interventions for Alzheimer's and related dementias. Am J Alzheimers Dis Other Demen (2009) 0.75
Clinical characterization in Alzheimer disease. Am J Alzheimers Dis Other Demen (2009) 0.75
Review of issue: caregiver depression and a plan to manage resistance to care. Am J Alzheimers Dis Other Demen (2011) 0.75
Interventions and diagnostics in Alzheimer's disease and related conditions. Am J Alzheimers Dis Other Demen (2010) 0.75
The media and cognitive health in our aging population. Am J Alzheimers Dis Other Demen (2009) 0.75
Barriers to hospice in patients with Alzheimer. Am J Alzheimers Dis Other Demen (2009) 0.75
Review of issue: the impact of time of day, mood, and caregiver stress on function in patients with dementia. Am J Alzheimers Dis Other Demen (2010) 0.75
The corpus callosum in Pick's disease, Alzheimer's disease, and amyotrophic lateral sclerosis: gliosis implies possible clinical consequence. Am J Alzheimers Dis Other Demen (2006) 0.75
Safety, end-of-life issues, and dealing with sexually inappropriate behavior in dementia patients. Am J Alzheimers Dis Other Demen (2008) 0.75
Strategies for patient diagnosis and management. Am J Alzheimers Dis Other Demen (2009) 0.75
Focusing on the caregiver: grief in dementia caregiving. Am J Alzheimers Dis Other Demen (2010) 0.75
Primary progressive aphasia and caregiver issues. Am J Alzheimers Dis Other Demen (2009) 0.75
Review of issue: studies on veterans, a useful pain scale, and plasma amyloid levels as a predictor of response to medications. Am J Alzheimers Dis Other Demen (2008) 0.75
Review of issue: changing environment and activities for the patients with dementia: what can we do to ease the burden? Am J Alzheimers Dis Other Demen (2010) 0.75